Nectar Laboratories Private Limited - Due diligence report

A 360° intelligence report on Nectar Laboratories Private Limited: trust score, financial health, credit view, compliance, directors, growth…

1994-03-10 Hyderabad, Telangana Active Unlisted Active Compliant
Share
Connect MCP
NL Nectar Laboratories Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Nectar Laboratories Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
87/100
Trust Score
Low Risk

Nectar Laboratories Private Limited is assessed as Low Risk with a Trust Score of 87/100. Nectar Laboratories Private Limited is an active private limited indian non-government company incorporated in 1994, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.

Report generated on 09 Aug 2026 from the latest processed filings. Nectar Laboratories Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
87/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
72/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
70/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 70/100 Moderate
  • Liabilities ≈ 38% EBITDA - stretched.
  • No open charges - unencumbered balance sheet.
  • Moderate gearing (D/E 1.42).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 6 satisfied (5.85 cr).

Banking relationships (from registered charges)
LenderChargesAmount
State Bank Of Hyderabad4 48.0 cr
Industrial Development Bank Of India2 48.0 cr
Compliance Score: 72/100 Moderate
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Litigation present in 3 court forum(s).
  • Delayed payments to MSME suppliers disclosed (3 disclosure(s)).
Legal cases on record (3)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
JYOTHSNA SUNIL MYSORE 01234567 Director 01/04/2018 6 yrs Approved
VEERRAJU GOLLA 01234567 Director 01/04/2018 6 yrs Approved
DARLA PRASAD 01234567 Director 01/04/2018 6 yrs Approved
SUNOJ MYSORE 01234567 Director 01/04/2018 6 yrs Approved
  • 4 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
6 allotment(s) · 2 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 70 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
Operating for 32+ years.
Distress signals & risk flags
MSME payment delays disclosed - latest outstanding 2,832.00.
3 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence82/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment78/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view83/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
11 Dec 2024
Director appointed
JYOTHSNA SUNIL MYSORE (Additional Director)
21 Dec 2022
Securities allotted
75000 Equity Shares - 75.00 Lakh raised
17 May 2022
Director ceased
RAMASWAMY NATESAIYER
25 Apr 2022
Director appointed
SUNOJ MYSORE (Director)
29 Sep 2021
Director ceased
DARLA PRASAD
02 Jun 2021
Director appointed
DARLA PRASAD (Director)
07 May 2021
Securities allotted
68000 Equity Shares - 68.00 Lakh raised
18 Mar 2021
Securities allotted
222000.00 Equity Shares - 2.22 cr raised
26 Nov 2020
Director ceased
PUVULA KANAKA RAO
19 Nov 2020
Director appointed
VEERRAJU GOLLA (Director)
10 Nov 2020
Director ceased
SAHADEV CHODON CHATOTH
31 Jan 2020
Charge satisfied
Industrial Development Bank Of India
30 May 2019
Director ceased
VIJAYARAJU GUPTA NAMA
10

Key Observations

Auto-generated from the data above
Revenue grew 24% over the last 4 financial year(s).
Net profit margin moved from 0.86 to 61%.
Debt-to-equity stands at 38% - manageable leverage.
Net worth is positive.
4 active director(s) / partner(s); board looks stable and experienced.
All 6 registered charge(s) stand satisfied - past borrowings repaid.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 6 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Cna Coatings India Private Limited U24304TZ2017PTC029241 Coimbatore, Tamil Nadu, India
Vinchem Industries Private Limited U24296DL2019PTC357577 Delhi, Delhi, India
Cbs Chemicals Private Limited U24231KA2021PTC144349 Bangalore, Karnataka, India
Atul Rubber Processors Private Limited U37200CT2011PTC022661 Raipur, Chattisgarh, India
Waksmed Lifescience Private Limited U51109KA2012PTC064577 Bangalore, Karnataka, India
Vallabh Pesticides Limited U24299GJ1982PLC005021 Anand, Gujarat, India
Titanium Technologies (India) Private Limited U24100DL2011PTC212981 New Delhi, Delhi, India
Anabiosis Medsciences Private Limited U24230GJ2015PTC084113 Sampa, Gujarat, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Nectar Laboratories Private Limited before audits and certifications: compliance score 72/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Nectar Laboratories Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 70/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 70/100, margin trends, ownership structure and peer set for Nectar Laboratories Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 87/100, distress signals and MSME payment-delay disclosures - know whether Nectar Laboratories Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (3 case(s) on record), regulatory flags, charge documents trail and director networks for Nectar Laboratories Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Nectar Laboratories Private Limited an active company?

Nectar Laboratories Private Limited has MCA status “Active” with a compliance score of 72/100 (Moderate).

Is Nectar Laboratories Private Limited financially healthy?

Nectar Laboratories Private Limited has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.

Should I do business with Nectar Laboratories Private Limited?

Its overall Trust Score is 87/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Nectar Laboratories Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 4 active director(s) are on record.

Does Nectar Laboratories Private Limited have loans or charges against its assets?

No open charges - all 6 registered charge(s) stand satisfied, indicating past borrowings were repaid.

Is Nectar Laboratories Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 72/100 (Moderate).

Is it risky to lend to Nectar Laboratories Private Limited?

Its Credit Risk Score is 70/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.